How Narrow or Broad Are ACA Marketplace Physician Networks?
(By Matthew Rae, Karen Pollitz, Kaye Pestaina, Michelle Long, Justin Lo, and Cynthia Cox for The Kaiser Family Foundation Published:
Read More
Health Insurance
Beyond cost, what barriers to health care do consumers face?
(By Imani Telesford, Aubrey Winger, and Matthew Rae for The Kaiser Family Foundation published August 22, 2024) Most adults (91%)
Read MoreDirect contracting grows: 6 key numbers
(By Jakob Emerson for Becker’s Hospital Review) As healthcare costs continue to rise, a growing number of employers are exploring
Read MoreThe 3 conditions driving healthcare costs up for employers: Report
(By Mariah Taylor for Becker’s Hospital Review) Pharmacy, cancer and musculoskeletal conditions remain the top drivers of increased healthcare costs
Read MoreHow Congress gets their health insurance
(By Rylee Wilson for Becker’s Hospital Review) Members of Congress are tasked with making decisions about the future of the
Read MoreBiden Administration Blocks Two Private Sector Enrollment Sites From ACA Marketplace
(By Julie Appleby for KFF Health News) Federal regulators have blocked two private sector enrollment websites from accessing consumer information
Read MoreLowest-rated Medicare Advantage plans in 2024: J.D. Power
(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage plans from Centene, Humana and UnitedHealthcare are among the lowest-rated plans
Read MoreEmployer healthcare costs to rise 9% in 2025: 5 notes
(By Rylee Wilson for Becker’s Hospital Review) The average cost of employer-sponsored healthcare coverage is expected to jump 9% from
Read MoreWhile Medicare Drug Price Negotiations Don’t Apply to Private Insurance, 3.4 Million People with Employer Coverage Take at Least One of the Selected Drugs
(Tammie Smith for The Kaiser Family Foundation published August 14, 2024) Among the 167 million people with employer-sponsored insurance in
Read MoreMajority of weight loss drug prescriptions going to commercially insured patients
(By Jakob Emerson for Becker’s Hospital Review) In 2023, more than 61% of Ozempic prescriptions went to patients with commercial
Read More